News

By Liz Switzer

Kathleen Cooney, MD, MACP, chair of the department, Aimee Zaas, MD, MHS, program director of the

With 2022 underway and we are still living a relentless pandemic, our health continues to be of the upmost importance and physical activity has been shown to not only improve health, but help prevent the onset of many diseases. In February we celebrate and raise awareness for Heart Month, a time when the national spotlight is on cardiovascular disease. One cardiologist at Duke focused on heart disease, specifically from a preventative standpoint, is Dr. William E. Kraus.

From the Director

In celebration of International Day of Women and Girls in Science, we are highlighting some of the inspiring women at Duke’s Center for Applied Genomics & Precision Medicine (CAGPM.) We spoke with them to learn more about their careers and what excites them about genomics.

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical center

More effective and equitable implementation of cancer screening represents a significant opportunity for the National Cancer Program, with the potential to reduce the burden of cancer, according to a report released February 2, 2022, by the President’s Cancer Panel. The Panel’s report, Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access, presents goals and recommendations to optimize cancer screening informed by a series of meetings conducted 2020-2021.

A Duke research team will play a key role in mapping cellular senescence in lung tissue as part of an NIH initiative to create a foundational database to identify senescent biomarkers that signal t

The February 8, 2022, session of Duke Medicine LEADS featured Bryan C. Batch, MD, MHS, Nia S.

Dr. Lori Orlando leads the team behind MeTree and studies decision modeling and implementation science as it relates to identifying and managing individuals in clinical settings at increased risk for medical conditions.